PERRIGO COMPANY PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.44 USD | -1.56% |
|
-7.35% | -14.47% |
| May. 07 | Perrigo's Q1 Adjusted Earnings, Net Sales Drop | MT |
| May. 07 | Transcript : Perrigo Company plc, Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
| Sales 2024 * | 4.62B | Sales 2025 * | 4.83B | Capitalization | 3.8B |
|---|---|---|---|---|---|
| Net income 2024 * | -74M | Net income 2025 * | 106M | EV / Sales 2024 * | 1.52 x |
| Net Debt 2024 * | 3.21B | Net Debt 2025 * | 3.01B | EV / Sales 2025 * | 1.41 x |
| P/E ratio 2024 * |
-19.2
x | P/E ratio 2025 * |
174
x | Employees | 9,140 |
| Yield 2024 * |
3.95% | Yield 2025 * |
4.2% | Free-Float | 99.66% |
More Fundamentals
* Assessed data
More news
Latest transcript on Perrigo Company plc
More recommendations
More press releases
More news
| 1 day | -0.85% | ||
| 1 week | -5.62% | ||
| Current month | -14.64% | ||
| 1 month | -12.71% | ||
| 3 months | +2.12% | ||
| 6 months | -9.33% | ||
| Current year | -13.36% |
1 week
27.60
29.77
1 month
27.6033.46
Current year
25.7734.60
1 year
25.7740.28
3 years
25.7750.90
5 years
25.7763.86
10 years
25.77215.73
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 23-06-29 | |
Eduardo Bezerra
DFI | Director of Finance/CFO | 49 | 22-05-15 |
Alison Ives
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Orlando Ashford
CHM | Chairman | 55 | 20-12-14 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 17-02-05 |
Bradley Alford
BRD | Director/Board Member | 67 | 17-02-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 18.63% | 13 M€ | -.--% | ||
| 15.31% | 254 M€ | +13.10% | - | |
| 0.66% | 8 M€ | +5.48% | - | |
| 0.46% | 2 M€ | 0.00% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-28 | 27.51 | -1.33% | 746 034 |
| 24-05-24 | 27.88 | -0.85% | 1,808,496 |
| 24-05-23 | 28.12 | -4.13% | 2,330,824 |
| 24-05-22 | 29.33 | -1.28% | 1,563,848 |
| 24-05-21 | 29.71 | +0.58% | 1,744,761 |
Delayed Quote Nyse, May 24, 2024 at 04:00 pm EDT
More quotes
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
Sector
Pharmaceuticals
Calendar
2024-05-30
- Ex-dividend day
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
27.88
USD
Average target price
39.5
USD
Spread / Average Target
+41.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -13.36% | 3.8B | |
| +38.51% | 727B | |
| +31.63% | 594B | |
| -6.23% | 354B | |
| +18.78% | 328B | |
| +1.35% | 277B | |
| +14.49% | 243B | |
| +7.42% | 205B | |
| -6.22% | 203B | |
| +6.19% | 164B |
- Stock Market
- Equities
- PRGO Stock
